These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24828321)

  • 1. HTA in Central and Eastern European countries; the 2001: A Space Odyssey and efficiency gain.
    Gulácsi L; Péntek M
    Eur J Health Econ; 2014 Sep; 15(7):675-80. PubMed ID: 24828321
    [No Abstract]   [Full Text] [Related]  

  • 2. Health technology assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria.
    Gulácsi L; Rotar AM; Niewada M; Löblová O; Rencz F; Petrova G; Boncz I; Klazinga NS
    Eur J Health Econ; 2014 May; 15 Suppl 1():S13-25. PubMed ID: 24832832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing challenges for sustainable healthcare in Central and Eastern Europe.
    Godman B; Novakovic T; Tesic D; Oortwijn W; Martin AP; Parker M; Haycox A
    Expert Rev Pharmacoecon Outcomes Res; 2016 Dec; 16(6):685-687. PubMed ID: 26966924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transferability of health technology assessment: the European perspective with focus on central and Eastern European countries.
    Németh B; Goettsch W; Kristensen FB; Piniazhko O; Huić M; Tesař T; Atanasijevic D; Lipska I; Kaló Z
    Expert Rev Pharmacoecon Outcomes Res; 2020 Aug; 20(4):321-330. PubMed ID: 32500749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTA Implementation Roadmap in Central and Eastern European Countries.
    Kaló Z; Gheorghe A; Huic M; Csanádi M; Kristensen FB
    Health Econ; 2016 Feb; 25 Suppl 1(Suppl Suppl 1):179-92. PubMed ID: 26763688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe.
    Malinowski KP; Kawalec P; Trąbka W; Sowada C; Petrova G; Manova M; Savova A; Draganić P; Slabý J; Männik A; Márky K; Rugaja Z; Gulbinovic J; Tesar T; Paveliu MS
    Orphanet J Rare Dis; 2020 Oct; 15(1):277. PubMed ID: 33032634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HEALTH TECHNOLOGY ASSESSMENT IN CENTRAL, EASTERN, AND SOUTH EUROPEAN COUNTRIES: CROATIA.
    Huic M; Tandara Hacek R; Svajger I
    Int J Technol Assess Health Care; 2017 Jan; 33(3):376-383. PubMed ID: 28803589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of health technology assessment in the process of implementation of the EU Transparency Directive: relevant experience from Central Eastern European countries.
    Kolasa K; Kalo Z; Zah V; Dolezal T
    Expert Rev Pharmacoecon Outcomes Res; 2012 Jun; 12(3):283-7. PubMed ID: 22812552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quo Vadis HTA for Medical Devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges.
    Daubner-Bendes R; Kovács S; Niewada M; Huic M; Drummond M; Ciani O; Blankart CR; Mandrik O; Torbica A; Yfantopoulos J; Petrova G; Holownia-Voloskova M; Taylor RS; Al M; Piniazhko O; Lorenzovici L; Tarricone R; Zemplényi A; Kaló Z
    Front Public Health; 2020; 8():612410. PubMed ID: 33490024
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving health care systems by building 'more Europe'.
    Antoñanzas F; Juárez-Castelló CA; Rodríguez-Ibeas R
    Eur J Health Econ; 2016 Sep; 17(7):787-9. PubMed ID: 27008028
    [No Abstract]   [Full Text] [Related]  

  • 11. Should Hungary Pay More for a QALY Gain than Higher-Income Western European Countries?
    Kovács S; Németh B; Erdősi D; Brodszky V; Boncz I; Kaló Z; Zemplényi A
    Appl Health Econ Health Policy; 2022 May; 20(3):291-303. PubMed ID: 35041177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transparency of published health technology assessment-based recommendations on pharmaceutical reimbursement in Poland.
    Bochenek T; Kocot E; Rodzinka M; Godman B; Maciejewska K; Kamal S; Pilc A
    Expert Rev Pharmacoecon Outcomes Res; 2017 Aug; 17(4):385-400. PubMed ID: 27882823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health technology assessment in Spain.
    Granados A; Sampietro-Colom L; Asua J; Conde J; Vazquez-Albertino R
    Int J Technol Assess Health Care; 2000; 16(2):532-59. PubMed ID: 10932423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health technology assessment and health care in the European Union.
    Banta D; Oortwijn W
    Int J Technol Assess Health Care; 2000; 16(2):626-35. PubMed ID: 10932427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HEALTH TECHNOLOGY ASSESSMENT IN CENTRAL-EASTERN AND SOUTH EUROPE COUNTRIES: BOSNIA AND HERZEGOVINA.
    Guzvic V; Catic T; Kostic M
    Int J Technol Assess Health Care; 2017 Jan; 33(3):390-395. PubMed ID: 28434417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eastern Europe: pronatalist policies and private behavior.
    David HP
    Popul Bull; 1982 Feb; 36(6):1-49. PubMed ID: 12338315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estonia: health system review.
    Lai T; Habicht T; Kahur K; Reinap M; Kiivet R; van Ginneken E
    Health Syst Transit; 2013; 15(6):1-196. PubMed ID: 24334730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health economics and health technology assessment in Central and Eastern Europe: a dose of reality.
    Gulácsi L; Orlewska E; Péntek M
    Eur J Health Econ; 2012 Oct; 13(5):525-31. PubMed ID: 22729215
    [No Abstract]   [Full Text] [Related]  

  • 19. OVERVIEW ON THE CURRENT IMPLEMENTATION OF HEALTH TECHNOLOGY ASSESSMENT IN THE HEALTHCARE SYSTEM IN HUNGARY.
    Németh B; Csanádi M; Kaló Z
    Int J Technol Assess Health Care; 2017 Jan; 33(3):333-338. PubMed ID: 28434433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'HTA for Crisis': sharing experiences during the 7th EBHC Symposium.
    Wladysiuk M; Tabor A; Godman B
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):47-9. PubMed ID: 23402445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.